Highbridge and its affiliates manage approximately $30 billion in capital for prominent institutional investors including pension funds, sovereign wealth funds, endowments, and foundations.
In 2004, J.P. Morgan Asset Management purchased a majority interest in Highbridge and completed its purchase of all remaining shares of the firm in 2009—a transaction that remains at the forefront of the hedge fund industry’s institutionalization. In fall 2012, Dubin led a group of global investors in the structuring and acquisition of Castleton Commodities International, LLC.
Dubin is a founding board member and former board Chair of the Robin Hood Foundation, an organization in New York that applies investment principles to charitable giving. He also serves as a board member of Mount Sinai Medical Center, the Museum of Modern Art, and is a member of the Dean’s Executive Committee of the Harvard Kennedy School.
Dubin graduated from the State University of New York at Stony Brook.